265 related articles for article (PubMed ID: 29016837)
1. Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07).
Beier D; Proescholdt M; Reinert C; Pietsch T; Jones DTW; Pfister SM; Hattingen E; Seidel C; Dirven L; Luerding R; Reijneveld J; Warmuth-Metz M; Bonsanto M; Bremer M; Combs SE; Rieken S; Herrlinger U; Kuntze H; Mayer-Steinacker R; Moskopp D; Schneider T; Beringer A; Schlegel U; Stummer W; Welker H; Weyerbrock A; Paulsen F; Rutkowski S; Weller M; Wick W; Kortmann RD; Bogdahn U; Hau P
Neuro Oncol; 2018 Feb; 20(3):400-410. PubMed ID: 29016837
[TBL] [Abstract][Full Text] [Related]
2. Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study.
Friedrich C; von Bueren AO; von Hoff K; Kwiecien R; Pietsch T; Warmuth-Metz M; Hau P; Deinlein F; Kuehl J; Kortmann RD; Rutkowski S
Eur J Cancer; 2013 Mar; 49(4):893-903. PubMed ID: 23182688
[TBL] [Abstract][Full Text] [Related]
3. Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.
Robinson GW; Rudneva VA; Buchhalter I; Billups CA; Waszak SM; Smith KS; Bowers DC; Bendel A; Fisher PG; Partap S; Crawford JR; Hassall T; Indelicato DJ; Boop F; Klimo P; Sabin ND; Patay Z; Merchant TE; Stewart CF; Orr BA; Korbel JO; Jones DTW; Sharma T; Lichter P; Kool M; Korshunov A; Pfister SM; Gilbertson RJ; Sanders RP; Onar-Thomas A; Ellison DW; Gajjar A; Northcott PA
Lancet Oncol; 2018 Jun; 19(6):768-784. PubMed ID: 29778738
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of reduced-dose craniospinal irradiation and combination chemotherapy for children with newly diagnosed medulloblastoma: A report from the Japanese Pediatric Brain Tumor Consortium.
Okada K; Soejima T; Sakamoto H; Hirato J; Hara J
Pediatr Blood Cancer; 2020 Nov; 67(11):e28572. PubMed ID: 32710713
[TBL] [Abstract][Full Text] [Related]
5. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
[TBL] [Abstract][Full Text] [Related]
6. Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961.
Packer RJ; Zhou T; Holmes E; Vezina G; Gajjar A
Neuro Oncol; 2013 Jan; 15(1):97-103. PubMed ID: 23099653
[TBL] [Abstract][Full Text] [Related]
7. Medulloblastoma in adults : A retrospective single institution analysis.
Hadi I; Roengvoraphoj O; Niyazi M; Roeder F; Schüller U; Belka C; Nachbichler SB
Strahlenther Onkol; 2018 Mar; 194(3):225-234. PubMed ID: 29147840
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy after reduced craniospinal irradiation dose in children with average-risk medulloblastoma: a 5-year follow-up study.
Wahba HA; Abu-Hegazy M; Wasel Y; Ismail EI; Zidan AS
J BUON; 2013; 18(2):425-9. PubMed ID: 23818356
[TBL] [Abstract][Full Text] [Related]
9. Hyperfractionated Accelerated Radiotherapy (HART) with maintenance chemotherapy for metastatic (M1-3) Medulloblastoma--a safety/feasibility study.
Taylor RE; Howman AJ; Wheatley K; Brogden EE; Large B; Gibson MJ; Robson K; Mitra D; Saran F; Michalski A; Pizer BL
Radiother Oncol; 2014 Apr; 111(1):41-6. PubMed ID: 24630538
[TBL] [Abstract][Full Text] [Related]
10. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R
J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538
[TBL] [Abstract][Full Text] [Related]
11. Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience.
Atalar B; Ozsahin M; Call J; Napieralska A; Kamer S; Villa S; Erpolat P; Negretti L; Lassen-Ramshad Y; Onal C; Akyurek S; Ugurluer G; Baumert BG; Servagi-Vernat S; Miller RC; Ozyar E; Sio TT
Radiother Oncol; 2018 Apr; 127(1):96-102. PubMed ID: 29373196
[TBL] [Abstract][Full Text] [Related]
12. Adult medulloblastoma: multiagent chemotherapy.
Greenberg HS; Chamberlain MC; Glantz MJ; Wang S
Neuro Oncol; 2001 Jan; 3(1):29-34. PubMed ID: 11305414
[TBL] [Abstract][Full Text] [Related]
13. Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma).
Goldwein JW; Radcliffe J; Johnson J; Moshang T; Packer RJ; Sutton LN; Rorke LB; D'Angio GJ
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):899-904. PubMed ID: 8598368
[TBL] [Abstract][Full Text] [Related]
14. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.
Packer RJ; Goldwein J; Nicholson HS; Vezina LG; Allen JC; Ris MD; Muraszko K; Rorke LB; Wara WM; Cohen BH; Boyett JM
J Clin Oncol; 1999 Jul; 17(7):2127-36. PubMed ID: 10561268
[TBL] [Abstract][Full Text] [Related]
15. Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology.
von Bueren AO; von Hoff K; Pietsch T; Gerber NU; Warmuth-Metz M; Deinlein F; Zwiener I; Faldum A; Fleischhack G; Benesch M; Krauss J; Kuehl J; Kortmann RD; Rutkowski S
Neuro Oncol; 2011 Jun; 13(6):669-79. PubMed ID: 21636711
[TBL] [Abstract][Full Text] [Related]
16. Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study.
Dirven L; Luerding R; Beier D; Bumes E; Reinert C; Seidel C; Bonsanto MM; Bremer M; Rieken S; Combs SE; Herrlinger U; Seliger C; Kuntze H; Mayer-Steinacker R; Dieing A; Bartels C; Schnell O; Weyerbrock A; Seidel S; Grauer O; Nadji-Ohl M; Paulsen F; Weller M; Wick W; Hau P
J Neurooncol; 2020 May; 148(1):117-130. PubMed ID: 32367436
[TBL] [Abstract][Full Text] [Related]
17. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.
Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF
PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704
[TBL] [Abstract][Full Text] [Related]
18. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
Gajjar A; Chintagumpala M; Ashley D; Kellie S; Kun LE; Merchant TE; Woo S; Wheeler G; Ahern V; Krasin MJ; Fouladi M; Broniscer A; Krance R; Hale GA; Stewart CF; Dauser R; Sanford RA; Fuller C; Lau C; Boyett JM; Wallace D; Gilbertson RJ
Lancet Oncol; 2006 Oct; 7(10):813-20. PubMed ID: 17012043
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters.
von Bueren AO; Kortmann RD; von Hoff K; Friedrich C; Mynarek M; Müller K; Goschzik T; Zur Mühlen A; Gerber N; Warmuth-Metz M; Soerensen N; Deinlein F; Benesch M; Zwiener I; Kwiecien R; Faldum A; Bode U; Fleischhack G; Hovestadt V; Kool M; Jones D; Northcott P; Kuehl J; Pfister S; Pietsch T; Rutkowski S
J Clin Oncol; 2016 Dec; 34(34):4151-4160. PubMed ID: 27863192
[TBL] [Abstract][Full Text] [Related]
20. Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept.
Rieken S; Gaiser T; Mohr A; Welzel T; Witt O; Kulozik AE; Wick W; Debus J; Combs SE
BMC Cancer; 2010 Aug; 10():450. PubMed ID: 20731859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
